Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Professor Victoria Elegant is based in Hong Kong for Amgen and is Vice-President, JAPAC Regional Medical Head, and Site Head, China Research Site, Shangha. Prior to Amgen, Professor Elegant was the Vice-President, Regulatory and Medical Affairs, APAC, based in Shanghai for 10 years for Baxter, and Vice President, Medical Affairs, Asia for Baxalta. Â
Professor Elegant is a Fellow of the Faculty of Pharmaceutical Medicine UK (FPM), member of the FPM International Committee, and is an Adjunct Professor, Faculty of Medicine and member of the Board of Studies for the Masters in Pharmaceutical Medicine at the  University of New South Wales, Sydney, Australia. Â
She has published and spoken extensively on regulatory affairs, medical affairs and clinical development in the Asia Pacific region  and is President of the Asia Pacific chapter of the Medical Affairs Professional Society (MAPS). She is on the biotech advisory board to the Hong Kong Stock Exchange. Â
Professor Elegant holds a medical degree from the University of London, and is passionate about improving standards of care and outcomes for patients in Asia. She is also involved in initiatives to support women in leadership. Â
Dr. Scott Flanders is currently the Vice President of Medical Affairs at Dendreon Pharmaceuticals LLC, located in Seattle, WA.
Scott has worked over 24 years in the life sciences industry and Medical Affairs area. Before joining Dendreon in 2018, Dr. Flanders was with Astellas Pharma Global Development as the U.S. lead for health economics and outcomes research (HEOR) Oncology group responsible for strategy and execution of HEOR research to include the development of real world research protocols, pharmacoeconomic models, statistical analysis, and global publications.
Scott’s other professional experience includes serving as the Strategic Lead for Health Care Quality and Medical External Affairs and as National Director, Clinical Science and Outcomes Research Field Team, with Takeda Pharmaceuticals; the Associate Director, Regional Outcomes, with Ortho McNeil-Janssen (OMJ) Scientific Affairs; and Sr. Manager of Health Economics, with TAP Pharmaceutical Products Inc.
Scott has a Bachelor of Science degree in Business Administration (Finance) and a Master of Science degree in Health Care Administration from Trinity University, in San Antonio, TX. After working as a licensed Nursing Home Administrator, he received a Doctor of Philosophy degree in Health Services Research (Economic) from Saint Louis University, St. Louis, MO.
Scott lives with his wife in Seattle, Washington. He loves the listen to the Blues and play golf when the weather and time permits.
John Pracyk is an executive medical leader with deep expertise in the safe and effective design, development, and commercialization of medical devices. Clinically trained as a Neurological Surgeon he possesses an uncommon blend of business and medical expertise and is a passionate proponent of value-based care and outcomes-driven, evidence-based practices. Dr. Pracyk is a recognized thought leader and program architect in the development of collaborative healthcare delivery platforms with a proven track record of multidisciplinary program buildouts and care redesign successes. A servant leader who motivates high-performing teams to outpace innovation timelines, exceed expectations, and fuel organizational transformation.
Prior to joining Olympus, Dr. Pracyk held multiple leadership roles of increasing responsibility with DePuy Synthes-Spine, Johnson & Johnson Medical Devices. He began his MedTech career in 2016 as Franchise Medical Director where he fostered meaningful innovation to drive safety and value for patients worldwide. There he delivered deep medical and scientific insights to the R&D and commercial teams for product ideation and development, including conceptual, hands-on evaluation, and clinical research perspectives.
In 2017, Dr. Pracyk was tapped to be medically responsible for J&J’s Global Spine Platform as the Franchise Medical Leader leveraging integrated procedural solutions to drive innovation and answer unmet clinical needs. He forged relationships with internal and external stakeholders, including Key Opinion Leaders, practicing surgeons, global regulatory agencies, professional societies, and executive leadership teams from hospitals, health systems, and integrated delivery networks.
In 2018, Dr. Pracyk was appointed Integrated Leader of Preclinical Research, Clinical Research, and Medical Affairs (PCM), a newly integrated scientific platform for Spine. The PCM concept incorporates product development with preclinical and clinical research outcomes and unifies them within the context of Medical Affairs to substantiate safety, performance, and value. Their objective is to ensure that all platform decisions are medically informed, surgically literate, clinically relevant, and financially sustainable. His PCM team’s accomplishments were spotlighted in J&J’s Meet the Innovator series as they got out in front of all goals, condensed timetables to move ahead, and completed the clinical post market clinical follow up plans for the new European Medical Device Regulation a full year ahead of schedule.
Outside of Olympus, Dr. Pracyk is becoming a leading voice in the Medical Affairs Professional Society (MAPS) where he was elected President of the Americas Region, Treasurer of the Executive Committee, and Board Director. MAPS amplifies the individual voices of over 6100 medical professionals that serve patients from within 200+ medical device and pharmaceutical manufacturers. By contextualizing the real-world clinical needs of patients, providers, and policy makers MAPS succinctly translates science into value to deliver a strategically critical scientific perspective in today’s ever-changing global healthcare landscape.
Dr. Pracyk obtained his BS, MD and PhD degrees through the Early Identification and the Medical Scientist Training Programs at Duke University. He was competitively awarded research fellowships at Cambridge University and the National Institutes of Health. He received his Neurological Surgery training at Duke University & The George Washington University and then completed a clinical spine fellowship at the University of Iowa. In 2015, he obtained a healthcare focused MBA at the Haslam College of Business of The University of Tennessee. Dr. Pracyk is a Fellow of the American Association of Neurological Surgeons and the American College of Surgeons, as well as a Diplomate of the American Board of Neurological Surgery. He maintains active memberships in the Medical Affairs Professional Society, American Association of Neurological Surgeons, Congress of Neurological Surgeons, North American Spine Society, AO Spine, Phi Kappa Phi, and the American College of Healthcare Executives.
Danie is currently EVP, Medical Affairs at Kyowa Kirin and Chair of the Medical affairs Professional Society (MAPS) board. He is a senior pharmaceutical executive with 30 years’ experience mainly in Medical Affairs. He has a passion for modernising medical affairs and track record in leadership, people development, capability building and coaching. Danie is a qualified MD with a Masters in Clinical Pharmacology who combines medical and life science qualifications with an MBA. Danie has extensive experience building international teams, driving change and working in regulated markets for GlaxoSmithKline (GSK) across Europe, the Americas, Middle East, Africa, Australasia and Japan. He previously worked for Eli Lilly & Company for 17 years in different medical roles as well as marketing and sales. During his different roles, he was based in South Africa, United Kingdom and Australia. Before joining the Pharmaceutical Industry, Danie had his own primary care practice.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.